Good Life Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Sell |
6,102
-344
| -5% | -$13.2K | 0.01% | 455 |
|
|
2025
Q1 | $250K | Buy |
+6,446
| New | +$250K | 0.02% | 424 |
|
|
2024
Q4 | – | Sell |
-14,486
| Closed | -$592K | – | 535 |
|
|
2024
Q3 | $592K | Buy |
14,486
+6,864
| +90% | +$281K | 0.04% | 306 |
|
|
2024
Q2 | $293K | Buy |
7,622
+681
| +10% | +$26.2K | 0.02% | 362 |
|
|
2024
Q1 | $298K | Sell |
6,941
-3
| -0% | -$129 | 0.03% | 351 |
|
|
2023
Q4 | $257K | Buy |
6,944
+16
| +0.2% | +$593 | 0.03% | 359 |
|
|
2023
Q3 | $251K | Buy |
+6,928
| New | +$251K | 0.03% | 347 |
|
|
2022
Q3 | – | Sell |
-3,788
| Closed | -$206K | – | 354 |
|
|
2022
Q2 | $206K | Sell |
3,788
-1,094
| -22% | -$59.5K | 0.03% | 319 |
|
|
2022
Q1 | $266K | Buy |
4,882
+152
| +3% | +$8.28K | 0.03% | 313 |
|
|
2021
Q4 | $261K | Sell |
4,730
-106
| -2% | -$5.85K | 0.03% | 309 |
|
|
2021
Q3 | $231K | Buy |
+4,836
| New | +$231K | 0.03% | 311 |
|
|
2021
Q2 | – | Sell |
-4,531
| Closed | -$202K | – | 330 |
|
|
2021
Q1 | $202K | Buy |
4,531
+19
| +0.4% | +$847 | 0.04% | 299 |
|
|
2020
Q4 | $205K | Sell |
4,512
-225
| -5% | -$10.2K | 0.05% | 252 |
|
|
2020
Q3 | $223K | Sell |
4,737
-726
| -13% | -$34.2K | 0.06% | 208 |
|
|
2020
Q2 | $277K | Buy |
5,463
+83
| +2% | +$4.21K | 0.08% | 177 |
|
|
2020
Q1 | $255K | Sell |
5,380
-109
| -2% | -$5.17K | 0.09% | 171 |
|
|
2019
Q4 | $323K | Sell |
5,489
-165
| -3% | -$9.71K | 0.09% | 178 |
|
|
2019
Q3 | $303K | Sell |
5,654
-29
| -0.5% | -$1.55K | 0.09% | 177 |
|
|
2019
Q2 | $283K | Buy |
5,683
+1,443
| +34% | +$71.9K | 0.08% | 178 |
|
|
2019
Q1 | $223K | Buy |
+4,240
| New | +$223K | 0.07% | 212 |
|
|
2017
Q2 | – | Sell |
-3,823
| Closed | -$200K | – | 210 |
|
|
2017
Q1 | $200K | Buy |
+3,823
| New | +$200K | 0.1% | 185 |
|